Abstract
We describe a rare fulminant case of Epstein-Barr virus-associated hemophagocytic syndrome (HPS) in a 37-year-old female renal transplant patient, indistinguishable from severe sepsis clinically and in the laboratory. HPS involves rapidly escalating immune system activation, resulting in a cytokine cascade, which can, especially in immunocompromised patients, lead to multi-organ failure, and even death. Thirty-two Herpesviridae-associated HPS cases in renal transplant patients have been reported and are reviewed. Overall mortality is 47% (15/32 cases).
Keywords:
EBV; hemophagocytic syndrome; pancytopenia; renal transplantation.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
MeSH terms
-
Acyclovir / administration & dosage
-
Acyclovir / therapeutic use
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / therapeutic use*
-
Diarrhea / etiology
-
Drug Therapy, Combination
-
Epstein-Barr Virus Infections / complications*
-
Epstein-Barr Virus Infections / drug therapy
-
Epstein-Barr Virus Infections / mortality
-
Epstein-Barr Virus Infections / virology
-
Fatal Outcome
-
Female
-
Fever / etiology
-
Ganciclovir / administration & dosage
-
Ganciclovir / therapeutic use
-
Glomerulonephritis, IGA / surgery*
-
Herpesvirus 4, Human / isolation & purification*
-
Humans
-
Immunocompromised Host
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
Kidney Transplantation / adverse effects*
-
Lymphohistiocytosis, Hemophagocytic / diagnosis*
-
Lymphohistiocytosis, Hemophagocytic / drug therapy
-
Lymphohistiocytosis, Hemophagocytic / etiology
-
Lymphohistiocytosis, Hemophagocytic / mortality
-
Multiple Organ Failure / etiology*
-
Multiple Organ Failure / mortality
-
Oliguria / etiology
Substances
-
Antiviral Agents
-
Immunosuppressive Agents
-
Ganciclovir
-
Acyclovir